DK25691A - Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat) - Google Patents
Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat) Download PDFInfo
- Publication number
- DK25691A DK25691A DK025691A DK25691A DK25691A DK 25691 A DK25691 A DK 25691A DK 025691 A DK025691 A DK 025691A DK 25691 A DK25691 A DK 25691A DK 25691 A DK25691 A DK 25691A
- Authority
- DK
- Denmark
- Prior art keywords
- acat
- cholesterol
- bival
- block
- ligand compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000003446 ligand Substances 0.000 title abstract 2
- 102000004357 Transferases Human genes 0.000 title 1
- 108090000992 Transferases Proteins 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23293188A | 1988-08-16 | 1988-08-16 | |
| PCT/US1989/002572 WO1990002129A1 (en) | 1988-08-16 | 1989-06-16 | Bivalent ligands effective for blocking acat enzyme |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK25691A true DK25691A (da) | 1991-02-14 |
| DK25691D0 DK25691D0 (da) | 1991-02-14 |
Family
ID=22875168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK025691A DK25691D0 (da) | 1988-08-16 | 1991-02-14 | Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat) |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0429464B1 (da) |
| JP (1) | JPH04500506A (da) |
| KR (1) | KR900701792A (da) |
| AT (1) | ATE114311T1 (da) |
| DE (1) | DE68919475T2 (da) |
| DK (1) | DK25691D0 (da) |
| WO (1) | WO1990002129A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5304548A (en) * | 1988-08-16 | 1994-04-19 | The Upjohn Company | Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol |
| US5180717A (en) * | 1988-08-16 | 1993-01-19 | The Upjohn Company | Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol |
| WO1995027964A1 (en) * | 1994-04-12 | 1995-10-19 | Qualcomm Incorporated | Method and apparatus for freight transportation using a satellite navigation system |
| US20100234363A1 (en) * | 2007-09-19 | 2010-09-16 | Institute Of Medicinal Molecular Design, Inc. | Heterocyclic derivative having inhibitory activity on type-i 11 data-hydroxysteroid dehydrogenase |
| CN102015722A (zh) * | 2008-03-05 | 2011-04-13 | 贝林格尔.英格海姆国际有限公司 | 三环吡啶衍生物、包含此类化合物的药物、它们的用途及其制备方法 |
| US20120053197A1 (en) | 2010-02-19 | 2012-03-01 | Boehringer Ingelheim International Gmbh | Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| WO2013024130A1 (en) | 2011-08-17 | 2013-02-21 | Boehringer Ingelheim International Gmbh | Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation |
| CN107021940A (zh) * | 2017-05-03 | 2017-08-08 | 天津国际生物医药联合研究院 | 一种双哌嗪类化合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU529561B2 (en) * | 1979-02-13 | 1983-06-09 | Upjohn Company, The | Antiatherogenic 6-halofurochromones |
| US4412071A (en) * | 1982-05-17 | 1983-10-25 | The Upjohn Company | Antiatherosclerotic compositions |
-
1989
- 1989-06-16 AT AT89907579T patent/ATE114311T1/de not_active IP Right Cessation
- 1989-06-16 DE DE68919475T patent/DE68919475T2/de not_active Expired - Fee Related
- 1989-06-16 KR KR1019900700773A patent/KR900701792A/ko not_active Application Discontinuation
- 1989-06-16 EP EP89907579A patent/EP0429464B1/en not_active Expired - Lifetime
- 1989-06-16 JP JP1507138A patent/JPH04500506A/ja active Pending
- 1989-06-16 WO PCT/US1989/002572 patent/WO1990002129A1/en active IP Right Grant
-
1991
- 1991-02-14 DK DK025691A patent/DK25691D0/da unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0429464B1 (en) | 1994-11-23 |
| ATE114311T1 (de) | 1994-12-15 |
| DK25691D0 (da) | 1991-02-14 |
| DE68919475D1 (de) | 1995-01-05 |
| AU631801B2 (en) | 1992-12-10 |
| EP0429464A1 (en) | 1991-06-05 |
| DE68919475T2 (de) | 1995-05-11 |
| KR900701792A (ko) | 1990-12-04 |
| JPH04500506A (ja) | 1992-01-30 |
| WO1990002129A1 (en) | 1990-03-08 |
| AU3835889A (en) | 1990-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO904921L (no) | Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater. | |
| DK246587A (da) | 1-aralkylpyrazoler, fremgangsmaader til deres fremstilling og anvendelse til bekaempelse af skadelige organismer | |
| NO881697D0 (no) | Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene. | |
| DK362787A (da) | Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling | |
| DK273689A (da) | 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler | |
| DK25691D0 (da) | Bivalente ligandforbindelser og deres anvendelse til blokering af cholesterol-o-acyltransferaseenzymet (acat) | |
| NO875263D0 (no) | 2,3-disubstituerte isoksazolidiner, fremgangsmaate til deres fremstilling, midler inneholdende disse og deres anvendelse. | |
| DK435588A (da) | Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse | |
| NO883244D0 (no) | Aminoalkylerte hydroksyforbindelser og deres anvendelse som fungicider. | |
| NO862975L (no) | Kvaternaere oksalkylerte polykondensater, fremgangsmaate til deres fremstilling, og deres anvendelse. | |
| NO884639L (no) | Vannopploeselige l-tyrosinderivater og fremgangsmaate til deres fremstilling. | |
| NO880473L (no) | Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel. | |
| NO890894D0 (no) | 4-substituerte pyrazolo(3,4-alfa)pyrimidinderivater og fremgangsmaate for deres fremstilling. | |
| DK349688A (da) | Bomologe af humant aprotinin, vaertsstamme samt ekspressionsvektorer til deres fremstilling og deres anvendelse som laegemidler | |
| DK572785D0 (da) | Imidazolderivater, laegemidler indeholdende disse forbindelser og fremgangsmaader til deres fremstilling | |
| NO842938L (no) | Antracycylinderivater, fremgangsmaate til deres fremstilling og deres anvendelse som cytostatika | |
| NO840580L (no) | Tributylfenol-etersulfonater, deres anvendelse og fremgangsmaate til fremstilling av etersulfonater | |
| DK453184D0 (da) | 1-azolyl-substituerede oximethere, fremgangsmaade til fremstilling deraf og deres anvendelse som fungicider | |
| NO871375D0 (no) | Bis-tertiaerbutylamino-substituerte 1,3,5-triazinderivater, fremgangsmaate til deres fremstilling, legemidler inneholdende disse forbindelser og deres anvendelse. | |
| DK278986A (da) | Halogenalkyl- eller halogenalkylsilylsubstituerede pyridaziner, deres fremstilling og anvendelse som fungicider | |
| DK157187A (da) | Acyloxyhiophencarboxamider, deres fremstilling og anvendelse til bekaempelse af skadelige organismer | |
| DK120789A (da) | 4-pentafluorphenoxupiperidiner, en fremgangsmaade til deres fremstilling og anvendelse af disse som laegemiddel | |
| NO924516D0 (no) | Isoxazolylimidazolderivater, fremgangsmaater for fremstilling av disse, og deres anvendelse i legemidler | |
| NO894516L (no) | Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter. | |
| DK202884A (da) | Azolylethyl-benzyl-ether-derivater, fremgangsmaade til deres fremstilling og deres anvendelse som fungicider |